Global HEPES 麻豆原创 Growth 2025-2031

Publication ID:

LPI03253719

Publication Date:

March 21, 2025

Pages:

133

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global HEPES market size is predicted to grow from US$ 76.4 million in 2025 to US$ 129 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) is a zwitterionic sulfonic acid buffering agent; one of the twenty Good"s buffers. HEPES is widely used in cell culture, largely because it is better at maintaining physiological pH despite changes in carbon dioxide concentration (produced by aerobic respiration) when compared to bicarbonate buffers, which are also commonly used in cell culture.
Global 5 largest manufacturers of HEPES are Merck, Suzhou Yacoo, Hopax, Avantor and ITW Reagents, which make up nearly 40%. Among them, Merck dominates with nearly 10% production value share, followed by Suzhou Yacoo (9%) and Hopax (8%). Top manufacturers are based in North America, China and Europe.
North America is the largest market, holding a share over 40%, followed by China and Europe, with shares 20% and 22% separately.
Based on the product type, the HEPES is primarily split into HEPES Powder and HEPES Solution. The leading type is HEPES Powder, with a market share over 75%.
Based on the Application, the HEPES is primarily split into Cell Culture and IVD Reagents. The largest segment is Cell Culture, accounting for over 50%.
The 鈥淗EPES Industry Forecast鈥� looks at past sales and reviews total world HEPES sales in 2024, providing a comprehensive analysis by region and market sector of projected HEPES sales for 2025 through 2031. With HEPES sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HEPES industry.
This Insight Report provides a comprehensive analysis of the global HEPES landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HEPES portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global HEPES market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HEPES and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HEPES.
This report presents a comprehensive overview, market shares, and growth opportunities of HEPES market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
HEPES Powder
HEPES Solution
Segmentation by Application:
Cell Culture
IVD Reagents
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Thermo Fisher
Avantor
Lonza
Cytiva
Promega
ITW Reagents
Spectrum Chemical
Biological Industries
Bio-Techne
BioSpectra
Corning
FUJIFILM Irvine Scientific
Dojindo Laboratories
Hopax
Suzhou Yacoo
XZL Bio-Technology
Yunbang Bio-pharmaceutical
Nanjing Robiot
Huanggang Yongan
Key Questions Addressed in this Report
What is the 10-year outlook for the global HEPES market?
What factors are driving HEPES market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HEPES market opportunities vary by end market size?
How does HEPES break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global HEPES Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for HEPES by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for HEPES by Country/Region, 2020, 2024 & 2031
2.2 HEPES Segment by Type
2.2.1 HEPES Powder
2.2.2 HEPES Solution
2.3 HEPES Sales by Type
2.3.1 Global HEPES Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global HEPES Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global HEPES Sale Price by Type (2020-2025)
2.4 HEPES Segment by Application
2.4.1 Cell Culture
2.4.2 IVD Reagents
2.4.3 Others
2.5 HEPES Sales by Application
2.5.1 Global HEPES Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global HEPES Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global HEPES Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global HEPES Breakdown Data by Company
3.1.1 Global HEPES Annual Sales by Company (2020-2025)
3.1.2 Global HEPES Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global HEPES Annual Revenue by Company (2020-2025)
3.2.1 Global HEPES Revenue by Company (2020-2025)
3.2.2 Global HEPES Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global HEPES Sale Price by Company
3.4 Key Manufacturers HEPES Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HEPES Product Location Distribution
3.4.2 Players HEPES Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for HEPES by Geographic Region
4.1 World Historic HEPES 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global HEPES Annual Sales by Geographic Region (2020-2025)
4.1.2 Global HEPES Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic HEPES 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global HEPES Annual Sales by Country/Region (2020-2025)
4.2.2 Global HEPES Annual Revenue by Country/Region (2020-2025)
4.3 Americas HEPES Sales Growth
4.4 APAC HEPES Sales Growth
4.5 Europe HEPES Sales Growth
4.6 Middle East & Africa HEPES Sales Growth
5 Americas
5.1 Americas HEPES Sales by Country
5.1.1 Americas HEPES Sales by Country (2020-2025)
5.1.2 Americas HEPES Revenue by Country (2020-2025)
5.2 Americas HEPES Sales by Type (2020-2025)
5.3 Americas HEPES Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HEPES Sales by Region
6.1.1 APAC HEPES Sales by Region (2020-2025)
6.1.2 APAC HEPES Revenue by Region (2020-2025)
6.2 APAC HEPES Sales by Type (2020-2025)
6.3 APAC HEPES Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe HEPES by Country
7.1.1 Europe HEPES Sales by Country (2020-2025)
7.1.2 Europe HEPES Revenue by Country (2020-2025)
7.2 Europe HEPES Sales by Type (2020-2025)
7.3 Europe HEPES Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HEPES by Country
8.1.1 Middle East & Africa HEPES Sales by Country (2020-2025)
8.1.2 Middle East & Africa HEPES Revenue by Country (2020-2025)
8.2 Middle East & Africa HEPES Sales by Type (2020-2025)
8.3 Middle East & Africa HEPES Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HEPES
10.3 Manufacturing Process Analysis of HEPES
10.4 Industry Chain Structure of HEPES
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HEPES Distributors
11.3 HEPES Customer
12 World Forecast Review for HEPES by Geographic Region
12.1 Global HEPES 麻豆原创 Size Forecast by Region
12.1.1 Global HEPES Forecast by Region (2026-2031)
12.1.2 Global HEPES Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global HEPES Forecast by Type (2026-2031)
12.7 Global HEPES Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck HEPES Product Portfolios and Specifications
13.1.3 Merck HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Thermo Fisher
13.2.1 Thermo Fisher Company Information
13.2.2 Thermo Fisher HEPES Product Portfolios and Specifications
13.2.3 Thermo Fisher HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thermo Fisher Main Business Overview
13.2.5 Thermo Fisher Latest Developments
13.3 Avantor
13.3.1 Avantor Company Information
13.3.2 Avantor HEPES Product Portfolios and Specifications
13.3.3 Avantor HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Avantor Main Business Overview
13.3.5 Avantor Latest Developments
13.4 Lonza
13.4.1 Lonza Company Information
13.4.2 Lonza HEPES Product Portfolios and Specifications
13.4.3 Lonza HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lonza Main Business Overview
13.4.5 Lonza Latest Developments
13.5 Cytiva
13.5.1 Cytiva Company Information
13.5.2 Cytiva HEPES Product Portfolios and Specifications
13.5.3 Cytiva HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cytiva Main Business Overview
13.5.5 Cytiva Latest Developments
13.6 Promega
13.6.1 Promega Company Information
13.6.2 Promega HEPES Product Portfolios and Specifications
13.6.3 Promega HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Promega Main Business Overview
13.6.5 Promega Latest Developments
13.7 ITW Reagents
13.7.1 ITW Reagents Company Information
13.7.2 ITW Reagents HEPES Product Portfolios and Specifications
13.7.3 ITW Reagents HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ITW Reagents Main Business Overview
13.7.5 ITW Reagents Latest Developments
13.8 Spectrum Chemical
13.8.1 Spectrum Chemical Company Information
13.8.2 Spectrum Chemical HEPES Product Portfolios and Specifications
13.8.3 Spectrum Chemical HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Spectrum Chemical Main Business Overview
13.8.5 Spectrum Chemical Latest Developments
13.9 Biological Industries
13.9.1 Biological Industries Company Information
13.9.2 Biological Industries HEPES Product Portfolios and Specifications
13.9.3 Biological Industries HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biological Industries Main Business Overview
13.9.5 Biological Industries Latest Developments
13.10 Bio-Techne
13.10.1 Bio-Techne Company Information
13.10.2 Bio-Techne HEPES Product Portfolios and Specifications
13.10.3 Bio-Techne HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bio-Techne Main Business Overview
13.10.5 Bio-Techne Latest Developments
13.11 BioSpectra
13.11.1 BioSpectra Company Information
13.11.2 BioSpectra HEPES Product Portfolios and Specifications
13.11.3 BioSpectra HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 BioSpectra Main Business Overview
13.11.5 BioSpectra Latest Developments
13.12 Corning
13.12.1 Corning Company Information
13.12.2 Corning HEPES Product Portfolios and Specifications
13.12.3 Corning HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Corning Main Business Overview
13.12.5 Corning Latest Developments
13.13 FUJIFILM Irvine Scientific
13.13.1 FUJIFILM Irvine Scientific Company Information
13.13.2 FUJIFILM Irvine Scientific HEPES Product Portfolios and Specifications
13.13.3 FUJIFILM Irvine Scientific HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 FUJIFILM Irvine Scientific Main Business Overview
13.13.5 FUJIFILM Irvine Scientific Latest Developments
13.14 Dojindo Laboratories
13.14.1 Dojindo Laboratories Company Information
13.14.2 Dojindo Laboratories HEPES Product Portfolios and Specifications
13.14.3 Dojindo Laboratories HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Dojindo Laboratories Main Business Overview
13.14.5 Dojindo Laboratories Latest Developments
13.15 Hopax
13.15.1 Hopax Company Information
13.15.2 Hopax HEPES Product Portfolios and Specifications
13.15.3 Hopax HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Hopax Main Business Overview
13.15.5 Hopax Latest Developments
13.16 Suzhou Yacoo
13.16.1 Suzhou Yacoo Company Information
13.16.2 Suzhou Yacoo HEPES Product Portfolios and Specifications
13.16.3 Suzhou Yacoo HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Suzhou Yacoo Main Business Overview
13.16.5 Suzhou Yacoo Latest Developments
13.17 XZL Bio-Technology
13.17.1 XZL Bio-Technology Company Information
13.17.2 XZL Bio-Technology HEPES Product Portfolios and Specifications
13.17.3 XZL Bio-Technology HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 XZL Bio-Technology Main Business Overview
13.17.5 XZL Bio-Technology Latest Developments
13.18 Yunbang Bio-pharmaceutical
13.18.1 Yunbang Bio-pharmaceutical Company Information
13.18.2 Yunbang Bio-pharmaceutical HEPES Product Portfolios and Specifications
13.18.3 Yunbang Bio-pharmaceutical HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Yunbang Bio-pharmaceutical Main Business Overview
13.18.5 Yunbang Bio-pharmaceutical Latest Developments
13.19 Nanjing Robiot
13.19.1 Nanjing Robiot Company Information
13.19.2 Nanjing Robiot HEPES Product Portfolios and Specifications
13.19.3 Nanjing Robiot HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Nanjing Robiot Main Business Overview
13.19.5 Nanjing Robiot Latest Developments
13.20 Huanggang Yongan
13.20.1 Huanggang Yongan Company Information
13.20.2 Huanggang Yongan HEPES Product Portfolios and Specifications
13.20.3 Huanggang Yongan HEPES Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Huanggang Yongan Main Business Overview
13.20.5 Huanggang Yongan Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.